Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy

International Journal of Pharmaceutics

Volumn 505, Issue 1-2, 2016, Pages 167-174

  Wu, Yong ^a   Petrochenko, Peter ^b   Chen, Lynn ^a   Wong, Sook Yee ^b   Absar, Mohammad ^b   Choi, Stephanie ^b   Zheng, Jiwen ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Core size; Cryo TEM; Intravenous iron; Nanoscale pharmaceutics; Physicochemical characterization

Indexed keywords

FERRIC GLUCONATE; FERRIC HYDROXIDE; FERUMOXYTOL; IRON DEXTRAN; IRON SACCHARATE; FERRIC ION; FERRIC OXIDE, SACCHARATED; FERROUS GLUCONATE; FERROUS ION; MAGNETITE; NANOPARTICLE; SACCHARIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; FOOD FREEZING; PHYSICAL CHEMISTRY; PRESERVATION; PRIORITY JOURNAL; SUSPENSION; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; DRUG FORMULATION; INTRAVENOUS DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PROCEDURES; TEMPERATURE;

ADMINISTRATION, INTRAVENOUS; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DYNAMIC LIGHT SCATTERING; FERRIC COMPOUNDS; FERROSOFERRIC OXIDE; FERROUS COMPOUNDS; GLUCARIC ACID; IRON-DEXTRAN COMPLEX; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; TEMPERATURE;

EID: 84962909345     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2016.03.029     Document Type: Article

References (52)

1. M. Alhede, K. Qvortrup, R. Liebrechts, N. Hoiby, M. Givskov, and T. Bjarnsholt Combination of microscopic techniques reveals a comprehensive visual impression of biofilm structure and composition FEMS Immunol. Med. Microbiol. 65 2012 335 342
2. T. Avni, A. Bieber, A. Grossman, H. Green, L. Leibovici, and A. Gafter-Gvili The safety of intravenous iron preparations: systematic review and meta-analysis Mayo Clin. Proc. 90 2015 12 23
3. G.R. Bailie, J.A. Clark, C.E. Lane, and P.L. Lane Hypersensitivity reactions and deaths associated with intravenous iron preparations Nephrol. Dialysis Transplant. 20 2005 1443 1449
4. V.S. Balakrishnan, M. Rao, A.T. Kausz, L. Brenner, B.J. Pereira, T.B. Frigo, and J.M. Lewis Physicochemical properties of ferumoxytol, a new intravenous iron preparation Eur. J. Clin. Invest. 39 2009 489 496
5. B.S. Barot, P.B. Parejiya, D.M. Mehta, P.K. Shelat, and G.B. Shah Physicochemical and structural characterization of iron-sucrose formulations: a comparative study Pharm. Dev. Technol. 19 2014 513 520
6. G. Borchard, B. Flühmann, and S. Mühlebach Nanoparticle iron medicinal products - requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies Regul. Toxicol. Pharm. 64 2012 324 328
7. G. Borchard, B. Flühmann, and S. Mühlebach Nanoparticle iron medicinal products - requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies Regul. Toxicol. Pharm. 64 2012 324 328
8. J.J. Bozzola, and L.D. Russell Electron Microscopy: Principles and Techniques for Biologists 2nd ed. 1999 Jones and Bartlett Sudbury, MA
9. J. Bullivant, S. Zhao, B. Willenberg, B. Kozissnik, C. Batich, and J. Dobson Materials characterization of Feraheme/Ferumoxytol and preliminary evaluation of its potential for magnetic fluid hyperthermia Int. J. Mol. Sci. 14 2013 17501
10. R.D. Cançado, and M. Muñoz Intravenous iron therapy: how far have we come? Rev. Bras. Hematol. Hemoter. 33 2011 461 469
11. J.M. Cash, and D.A. Sears The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients Am. J. Med. 87 1989 638 644
12. S. Chen Polymer-coated iron oxide nanoparticles for medical imaging PhD Thesis 2010 Massachusetts Institute of Technology Cambridge, MA http://dspace.mit.edu/handle/1721.1/59004
13. A.J. Cole, V.C. Yang, and A.E. David Cancer theranostics: the rise of targeted magnetic nanoparticles Trends Biotechnol. 29 2011 323 332
14. R.M. Cornell, and U. Schwertmann The Iron Oxides: Structure, Properties, Reactions, Occurrences and Uses 2006 Wiley
15. J.S.G. Cox, G.R. Kennedy, J. King, P.R. Marshall, and D. Rutherford Structure of an iron-dextran complex J. Pharm. Pharmacol. 24 1972 513 517
16. B. Danielson, T. Salmonson, H. Derendorf, and P. Geisser Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers Arzneimittelforschung 1996 615 621
17. M.J. Dobro, L.A. Melanson, G.J. Jensen, and A.W. McDowall Plunge freezing for electron cryomicroscopy Methods Enzymol. 481 2010 63 82
18. B.P. Esposito, W. Breuer, I. Slotki, and Z.I. Cabantchik Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients Eur. J. Clin. Invest. 32 Suppl. 1 2002 42 49
19. G. Fillet, J.D. Cook, and C.A. Finch Storage iron kinetics:VII. A biologic model for reticuloendothelial iron transport J. Clin. Invest. 53 1974 1527 1533
20. F. Funk, G. Long, D. Hautot, R. Büchi, I. Christl, and P. Weidler Physical and chemical characterization of therapeutic iron containing materials: a study of several superparamagnetic drug formulations with the β-FeOOH or ferrihydrite structure Hyperfine Interact. 136-137 2001 73 95
21. S. Futterer, I. Andrusenko, U. Kolb, W. Hofmeister, and P. Langguth Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD) J. Pharm. Biomed. Anal. 86 2013 151 160
22. X. Gao, and D.G. Schulze Precipitation and transformation of secondary Fe oxyhydroxides in a histosol impacted by runoff from a lead smelter Clays Clay Miner. 58 2010 377 387
23. P. Geisser, M. Baer, and E. Schaub Structure/histotoxicity relationship of parenteral iron preparations Arzneimittelforschung 42 1992 1439 1452
24. H. Graczyk, L.C. Bryan, N. Lewinski, G. Suarez, G. Coullerez, P. Bowen, and M. Riediker Physicochemical characterization of nebulized superparamagnetic iron oxide nanoparticles (SPIONs) J. Aerosol. Med. Pulm. Drug Deliv. 28 2015 43 51
25. Hackley, V.A., Clogston, J.D., November 2007. Revised, February 2010, NIST-NCL Joint Assay Protocol, PCC-1. Version 1.1 Measuring the Size of Nanoparticles in Aqueous Media Using Batch-Mode Dynamic Light Scattering.
26. C. Hershko, A. Abrahamov, A.M. Konijn, W. Breuer, I.Z. Cabantchik, P. Pootrakul, and G. Link Objectives and methods of iron chelation therapy Bioinorg. Chem. Appl. 2003 151 168
27. M.R. Jahn, H.B. Andreasen, S. Fütterer, T. Nawroth, V. Schünemann, U. Kolb, W. Hofmeister, M. Muñoz, K. Bock, M. Meldal, and P. Langguth A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer ®), a new intravenous iron preparation and its clinical implications Eur. J. Pharm. Biopharm. 78 2011 480 491
28. J. Kane, and M. Sternheim Physics 1978 John Wiley and Sons New York
29. M. Knutson, and M. Wessling-Resnick Iron metabolism in the reticuloendothelial system Crit. Rev. Biochem. Mol. Biol. 38 2003 61 88
30. M. Koralewski, M. Pochylski, and J. Gierszewski Magnetic properties of ferritin and akaganeite nanoparticles in aqueous suspension J. Nanopart. Res. 15 2013 1902
31. D.S. Kudasheva, J. Lai, A. Ulman, and M.K. Cowman Structure of carbohydrate-bound polynuclear iron oxyhydroxide nanoparticles in parenteral formulations J. Inorg. Biochem. 98 2004 1757 1769
32. D.S. Larson, and D.W. Coyne Update on intravenous iron choices Curr. Opin. Nephrol. Hypertens. 23 2014 186 191
33. R. Lawrence Development and comparison of iron dextran products PDA J. Pharm. Sci. Technol. 52 1998 190 197
34. H. Manley, and D. Grabe Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study BMC Nephrol. 5 2004 1 7
35. R.T. Means Jr., and S.B. Krantz Progress in understanding the pathogenesis of the anemia of chronic disease Blood 80 1992 1639 1647
36. T. Meier, P. Schropp, C. Pater, A.L. Leoni, V.V. Khov-Tran, and P. Elford Physicochemical and toxicological characterization of a new generic iron sucrose preparation Arzneimittelforschung 61 2011 112 119
37. S. Neiser, D. Rentsch, U. Dippon, A. Kappler, P.G. Weidler, J. Gottlicher, R. Steininger, M. Wilhelm, M. Braitsch, F. Funk, E. Philipp, and S. Burckhardt Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose Biometals 28 2015 615 635
38. E. Nemeth, and T. Ganz The role of hepcidin in iron metabolism Acta Haematol. 122 2009 78 86
39. J.A. Nissim Intravenous administration of iron Lancet 2 1947 49 51
40. T.M. Rooyakkers, E.S. Stroes, M.P. Kooistra, E.E. van Faassen, R.C. Hider, T.J. Rabelink, and J.J. Marx Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo Eur. J. Clin. Invest. 32 Suppl. 1 2002 9 16
41. D.S. Silverberg, D. Wexler, M. Blum, G. Keren, D. Sheps, E. Leibovitch, D. Brosh, S. Laniado, D. Schwartz, T. Yachnin, I. Shapira, D. Gavish, R. Baruch, B. Koifman, C. Kaplan, S. Steinbruch, and A. Iaina The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations J. Am. Coll. Cardiol. 35 2000 1737 1744
42. B.V. Stefansson, B. Haraldsson, and U. Nilsson Acute oxidative stress following intravenous iron injection in patients on chronic hemodialysis: a comparison of iron-sucrose and iron-dextran Nephron Clin. Pract. 118 2011 c249 256
43. J. Stein, F. Hartmann, and A.U. Dignass Diagnosis and management of iron deficiency anemia in patients with IBD Nat. Rev. Gastroenterol. Hepatol. 7 2010 599 610
44. R. Stoltzfus Defining iron-deficiency anemia in public health terms: a time for reflection J. Nutr. 131 2001 565S 567S
45. M.W.M. te Booy, R. de Ruiter, and A.J. de Meere Evaluation of the physical stability of freeze-Dried sucrose-Containing formulations by differential scanning calorimetry Pharm. Res. 9 1992 109 114
46. D. Van Wyck, J. Anderson, and K. Johnson Labile iron in parenteral iron formulations: a quantitative and comparative study Nephrol. Dial. Transplant. 19 2004 561 565
47. D.B. Van Wyck Labile iron: manifestations and clinical implications J. Am. Soc. Nephrol. 15 Suppl. 2 2004 S107 111
48. S. von Haehling, E.A. Jankowska, D.J. van Veldhuisen, P. Ponikowski, and S.D. Anker Iron deficiency and cardiovascular disease Nat. Rev. Cardiol. 12 2015 659 669
49. Y. Wang, H.S. Fan, Y.M. Xiao, Z.W. Gu, and X.D. Zhang A new way to prepare porous Polylactide/Hydroxyapatite scaffold at room temperature Key Eng. Mater. 2006 1083 1086
50. Y. Wu, J. Liang, K. Rensing, T.-M. Chou, and M. Libera Reorganization of S. aureus ECM during cryo-preparation for SEM imaging Microsc. Microanal. 20 2014 1228 1229
51. Y. Wu, J. Liang, K. Rensing, T.M. Chou, and M. Libera Extracellular matrix reorganization during cryo preparation for scanning electron microscope imaging of Staphylococcus aureus biofilms Microsc. Microanal. 20 2014 1348 1355
52. G. Yee, and W. Tolman Transition metal complexes and the activation of dioxygen P.M.H. Kroneck, M.E. Sosa Torres, Sustaining Life on Planet Earth: Metalloenzymes Mastering Dioxygen and Other Chewy Gases 2015 Springer International Publishing 131 204